Apotex first to receive Health Canada approval for SEVMIA™, a generic semaglutide for chronic weight management
TORONTO, June 30, 2026 /PRNewswire/ - Apotex Health Corp. ("Apotex" or the "Company") (TSX: APTX), the largest Canadian-based global health company, today announced it is the first to receive Health Canada's approval for a generic equivalent of Wegovy® (semaglutide injection) for chronic...
TORONTO, June 30, 2026 /PRNewswire/ - Apotex Health Corp. ("Apotex" or the "Company") (TSX: APTX), the largest Canadian-based global health company, today announced it is the first to receive Health Canada's approval for a generic equivalent of Wegovy® (semaglutide injection) for chronic...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.